Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

First Chimeric Antigen Receptor T-Cell Therapy Approved.

Brower V.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx251. No abstract available.

PMID:
29106609
2.

Adding radiotherapy to chemotherapy in advanced NSCLC.

Brower V.

Lancet Oncol. 2017 Nov;18(11):e645. doi: 10.1016/S1470-2045(17)30771-4. Epub 2017 Sep 28. No abstract available.

PMID:
28965744
3.

Counterfeit and substandard malaria drugs in Africa.

Brower V.

Lancet Infect Dis. 2017 Oct;17(10):1026-1027. doi: 10.1016/S1473-3099(17)30528-5. No abstract available. Erratum in: Lancet Infect Dis. 2017 Nov 22;:.

PMID:
28948928
4.

Atezolizumab in advanced non-small-cell lung cancer.

Brower V.

Lancet Oncol. 2017 Aug;18(8):e434. doi: 10.1016/S1470-2045(17)30504-1. Epub 2017 Jun 22. No abstract available.

PMID:
28648559
5.

First-line abiraterone improves survival in prostate cancer.

Brower V.

Lancet Oncol. 2017 Jul;18(7):e374. doi: 10.1016/S1470-2045(17)30452-7. Epub 2017 Jun 8. No abstract available.

PMID:
28602778
6.

Naldemedine effective in treating opioid-induced constipation.

Brower V.

Lancet Oncol. 2017 Jun;18(6):e306. doi: 10.1016/S1470-2045(17)30320-0. Epub 2017 May 5. No abstract available.

PMID:
28483411
7.

Pregnancy complications in survivors of childhood cancer.

Brower V.

Lancet Oncol. 2017 Jun;18(6):e303. doi: 10.1016/S1470-2045(17)30316-9. Epub 2017 Apr 28. No abstract available.

PMID:
28457709
8.

Immune Checkpoint Inhibitors Effective in Urothelial Cancer.

Brower V.

J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djx110. No abstract available.

PMID:
30053144
9.

Pembrolizumab in advanced head and neck cancer.

Brower V.

Lancet Oncol. 2017 May;18(5):e248. doi: 10.1016/S1470-2045(17)30245-0. Epub 2017 Mar 30. No abstract available.

PMID:
28366274
10.

Pravastatin has no advantage in small-cell lung cancer.

Brower V.

Lancet Oncol. 2017 Apr;18(4):e204. doi: 10.1016/S1470-2045(17)30184-5. Epub 2017 Mar 10. No abstract available.

PMID:
28285843
11.

Clofarabine-based consolidation therapy in AML.

Brower V.

Lancet Oncol. 2017 Apr;18(4):e201. doi: 10.1016/S1470-2045(17)30177-8. Epub 2017 Mar 3. No abstract available.

PMID:
28262461
12.

Scalp cooling and hair loss during breast cancer chemotherapy.

Brower V.

Lancet Oncol. 2017 Apr;18(4):e199. doi: 10.1016/S1470-2045(17)30158-4. Epub 2017 Feb 24. No abstract available.

PMID:
28238594
13.

Bicalutamide with radiotherapy for prostate cancer.

Brower V.

Lancet Oncol. 2017 Mar;18(3):e141. doi: 10.1016/S1470-2045(17)30097-9. Epub 2017 Feb 10. No abstract available.

PMID:
28190764
14.

Letrozole not superior to anastrozole for early breast cancer.

Brower V.

Lancet Oncol. 2017 Mar;18(3):e138. doi: 10.1016/S1470-2045(17)30081-5. Epub 2017 Feb 3. No abstract available.

PMID:
28163005
15.

Researchers Identify High-Risk Subtype of Stage I Lung Cancer.

Brower V.

J Natl Cancer Inst. 2017 Jan;109(1):3-4. doi: 10.1093/jnci/djw334. No abstract available.

PMID:
28104783
16.

Suicide in survivors of childhood and young adult cancers.

Brower V.

Lancet Oncol. 2016 Dec;17(12):e522. doi: 10.1016/S1470-2045(16)30554-X. Epub 2016 Oct 27. No abstract available.

PMID:
28100435
17.

Pioglitazone with imatinib in CML may reduce residual disease.

Brower V.

Lancet Oncol. 2017 Feb;18(2):e70. doi: 10.1016/S1470-2045(17)30010-4. Epub 2017 Jan 7. No abstract available.

PMID:
28089103
18.

Onartuzumab ineffective in non-small-cell lung cancer.

Brower V.

Lancet Oncol. 2017 Feb;18(2):e66. doi: 10.1016/S1470-2045(16)30680-5. Epub 2016 Dec 23. No abstract available.

PMID:
28017663
19.

Genomics Studies in Esophageal Cancers Yield New Approaches.

Brower V.

J Natl Cancer Inst. 2016 Dec 16;108(12). pii: djw308. Print 2016 Dec. No abstract available.

PMID:
27986887
20.

Chimeric Antigen Receptor T-Cell Therapies Advancing.

Brower V.

J Natl Cancer Inst. 2016 Dec 5;108(11). pii: djw284. Print 2016 Nov. No abstract available.

PMID:
27920051
21.

Hyperprogressive disease with anti-PD-1 and anti-PD-L1.

Brower V.

Lancet Oncol. 2016 Dec;17(12):e527. doi: 10.1016/S1470-2045(16)30590-3. Epub 2016 Nov 18. No abstract available.

PMID:
27866860
22.

Phase 1/2 study of blinatumomab in relapsed paediatric ALL.

Brower V.

Lancet Oncol. 2016 Dec;17(12):e525. doi: 10.1016/S1470-2045(16)30580-0. Epub 2016 Nov 11. No abstract available.

PMID:
27839960
23.

Cord blood transplant improves outcomes in leukaemia.

Brower V.

Lancet Oncol. 2016 Oct;17(10):e425. doi: 10.1016/S1470-2045(16)30448-X. Epub 2016 Sep 16. No abstract available.

PMID:
27641477
24.

Sorafenib plus cisplatin for hepatocellular carcinoma.

Brower V.

Lancet Oncol. 2016 Oct;17(10):e424. doi: 10.1016/S1470-2045(16)30447-8. Epub 2016 Sep 9. No abstract available.

PMID:
27617663
25.

Tackling Mesothelioma With Immunotherapies.

Brower V.

J Natl Cancer Inst. 2016 Aug 10;108(8). pii: djw198. doi: 10.1093/jnci/djw198. Print 2016 Aug. No abstract available.

26.

Tasquinimod treatment for prostate cancer.

Brower V.

Lancet Oncol. 2016 Aug;17(8):e322. doi: 10.1016/S1470-2045(16)30272-8. No abstract available.

PMID:
27345634
27.

Anti-PD-L1 inhibitor durvalumab in bladder cancer.

Brower V.

Lancet Oncol. 2016 Jul;17(7):e275. doi: 10.1016/S1470-2045(16)30242-X. Epub 2016 Jun 16. No abstract available.

PMID:
27321156
28.

Physical frailty in survivors of haemopoietic cell transplant.

Brower V.

Lancet Oncol. 2016 Jul;17(7):e274. doi: 10.1016/S1470-2045(16)30226-1. Epub 2016 Jun 9. No abstract available.

PMID:
27290907
29.

Good outcomes for lymphoma treatment during pregnancy.

Brower V.

Lancet Oncol. 2016 Jul;17(7):e273. doi: 10.1016/S1470-2045(16)30208-X. Epub 2016 Jun 3. No abstract available.

PMID:
27267609
30.

Capecitabine and lapatinib treatment in head and neck cancer.

Brower V.

Lancet Oncol. 2016 Jul;17(7):e271. doi: 10.1016/S1470-2045(16)30200-5. Epub 2016 May 26. No abstract available.

PMID:
27237610
31.

SNP affects colorectal cancer outcomes with cetuximab.

Brower V.

Lancet Oncol. 2016 Jun;17(6):e230. doi: 10.1016/S1470-2045(16)30163-2. Epub 2016 May 19. No abstract available.

PMID:
27210534
32.

Bortezomib improves survival in rare myeloma.

Brower V.

Lancet Oncol. 2016 Jun;17(6):e227. doi: 10.1016/S1470-2045(16)30129-2. Epub 2016 May 6. No abstract available.

PMID:
27160479
33.

Chemotherapy benefit for paediatric neurofibromatosis type I.

Brower V.

Lancet Oncol. 2016 May;17(5):e186. doi: 10.1016/S1470-2045(16)30058-4. Epub 2016 Apr 14. No abstract available.

PMID:
27151167
34.

Cancer Stem Cell Hypothesis Evolves With Emerging Research.

Brower V.

J Natl Cancer Inst. 2016 Apr 29;108(5). pii: djw139. doi: 10.1093/jnci/djw139. Print 2016 May. No abstract available.

PMID:
27130920
35.

Crizotinib improves intracranial metastasis control.

Brower V.

Lancet Oncol. 2016 May;17(5):e184. doi: 10.1016/S1470-2045(16)30047-X. Epub 2016 Apr 7. No abstract available.

PMID:
27067831
36.

Adhesion Molecules, Stem Cells, and the Microenvironment in Acute Myeloid Leukemia.

Brower V.

J Natl Cancer Inst. 2016 Apr 2;108(4). pii: djw113. doi: 10.1093/jnci/djw113. Print 2016 Apr. No abstract available.

PMID:
27038119
37.

Apatinib in treatment of refractory gastric cancer.

Brower V.

Lancet Oncol. 2016 Apr;17(4):e137. doi: 10.1016/S1470-2045(16)00138-8. Epub 2016 Feb 26. No abstract available.

PMID:
26922857
38.

Deep Sequencing of Acute Myeloid Leukemia Reveals Driver Mutations and New Targets.

Brower V.

J Natl Cancer Inst. 2016 Feb 9;108(2). pii: djw018. doi: 10.1093/jnci/djw018. Print 2016 Feb. No abstract available.

PMID:
26864927
39.

Afatinib and chemotherapy in non-small-cell lung cancer.

Brower V.

Lancet Oncol. 2016 Feb;17(2):e47. doi: 10.1016/S1470-2045(15)00609-9. Epub 2015 Dec 18. No abstract available.

PMID:
26710711
40.

Venetoclax targets BCL2 in chronic lymphocytic leukaemia.

Brower V.

Lancet Oncol. 2016 Jan;17(1):e11. doi: 10.1016/S1470-2045(15)00576-8. Epub 2015 Dec 11. No abstract available.

PMID:
26687593
41.

Targeted Therapies Improve Outlook for Chronic Lymphocytic Leukemia.

Brower V.

J Natl Cancer Inst. 2015 Dec 11;107(12):djv396. doi: 10.1093/jnci/djv396. Print 2015 Dec. No abstract available.

PMID:
26657100
42.

American Society of Clinical Oncology Developing First Clinical Trial.

Brower V.

J Natl Cancer Inst. 2015 Nov 4;107(11):djv356. doi: 10.1093/jnci/djv356. Print 2015 Nov. No abstract available.

PMID:
26538625
43.

Modified gastric cancer chemotherapy: more effective, less toxic.

Brower V.

Lancet Oncol. 2015 Dec;16(16):e590. doi: 10.1016/S1470-2045(15)00442-8. Epub 2015 Oct 26. No abstract available.

PMID:
26511647
44.

ASCO Reveals Additional Promising Results With Immunotherapies.

Brower V.

J Natl Cancer Inst. 2015 Sep 30;107(10). pii: djv295. doi: 10.1093/jnci/djv295. Print 2015 Oct. No abstract available.

PMID:
26424738
45.

MRI study identifies three subtypes of glioblastoma.

Brower V.

Lancet Oncol. 2015 Oct;16(13):e484. doi: 10.1016/S1470-2045(15)00314-9. Epub 2015 Sep 11. No abstract available.

PMID:
26365415
46.

Hypofractionated breast radiation reduces acute toxicities.

Brower V.

Lancet Oncol. 2015 Sep;16(9):e432. doi: 10.1016/S1470-2045(15)00226-0. Epub 2015 Aug 13. No abstract available.

PMID:
26278161
47.

NCI-MATCH pairs tumor mutations with matching drugs.

Brower V.

Nat Biotechnol. 2015 Aug;33(8):790-1. doi: 10.1038/nbt0815-790. No abstract available.

PMID:
26252121
48.

American Association of Cancer Research Showcases Immunotherapy Advances.

Brower V.

J Natl Cancer Inst. 2015 Aug 4;107(8). pii: djv231. doi: 10.1093/jnci/djv231. Print 2015 Aug. No abstract available.

49.

Nodal radiation in breast cancer does not improve survival.

Brower V.

Lancet Oncol. 2015 Sep;16(9):e430. doi: 10.1016/S1470-2045(15)00203-X. Epub 2015 Jul 30. No abstract available.

PMID:
26234171
50.

Ibrutinib promising in subtype of DLBCL.

Brower V.

Lancet Oncol. 2015 Sep;16(9):e428. doi: 10.1016/S1470-2045(15)00192-8. Epub 2015 Jul 23. No abstract available.

PMID:
26212869

Supplemental Content

Loading ...
Support Center